Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2024-01-11 00:00:00 ET · period of report 2024-01-09 · accession 0001209191-24-001484 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-01-11	2024-01-09	RXRX	Borgeson Blake	Dir	S - Sale	$13.62	-20.1K	7.36M	-0.3%	-$273.2K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2024-01-09	S	D	13,751	$13.81	7,344,418	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.50 to $14.06 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2024-01-09	S	D	6,303	$13.21	7,358,169	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.5 to $13.495 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.